Ellenbogen Michael sold $480K of EVLV
Ellenbogen Michael sold 80,745 shares of Evolv Technologies Holdings, Inc. (EVLV) at $5.94 ($0.48M total) on 2026-07-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure confirms the size, price, and post-transaction holdings of a director’s open-market sale under a 10b5-1 plan, which typically has limited fundamental implications.
Market read
Provides a concrete insider-selling datapoint for EVLV, but without new company fundamentals.
What to watch
Traders may over-weight insider sales; the key missing context is whether other insiders also sold/bought around the same period and whether the company has upcoming catalysts.
Background
The article is an SEC Form 4 insider transaction filing for Evolv Technologies Holdings, Inc.
Ticker impact
Evolv Technologies director Michael Ellenbogen sold 80,745 shares in an open-market transaction worth about $479.6K under a 10b5-1 plan.
Likely limited, with any impact confined to short-term sentiment around insider selling.
The filing is a Form 4 insider transaction with a stated 10b5-1 pre-arranged plan; it provides a concrete datapoint but no new operational or financial guidance.
Market effects
No clear sector read-through from a single director sale disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is under a pre-arranged 10b5-1 plan, it may not signal reduced confidence and could be largely noise for traders.
Key entities
- issuerEvolv Technologies Holdings, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderMichael Ellenbogen
Director who executed the open-market sale under a 10b5-1 plan.
